PubMed for id: 927028876

Year	Number of Results
1995	1
1998	1
1999	1
2007	1
2008	1
2010	1
2011	1
2021	1
2022	1
2023	1
2024	0

1

TUBA1A licenses APC/C-mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3.

Wen J, Wang Q, Zhang W, Wang W. Wen J, et al. FEBS Lett. 2023 Dec;597(24):3072-3086. doi: 10.1002/1873-3468.14764. Epub 2023 Nov 7. FEBS Lett. 2023. PMID: 37873730

2

Inhibition of PLK3 Attenuates Tubular Epithelial Cell Apoptosis after Renal Ischemia-Reperfusion Injury by Blocking the ATM/P53-Mediated DNA Damage Response.

Deng W, Wei X, Xie Z, Zhang R, Dong Z, Zhang J, Luo Y, Cheng Q, Wang R, Li H, Na N. Deng W, et al. Oxid Med Cell Longev. 2022 Jun 24;2022:4201287. doi: 10.1155/2022/4201287. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35783188 Free PMC article.

3

Cell-Type-Specific Gene Expression in Developing Mouse Neocortex: Intermediate Progenitors Implicated in Axon Development.

Bedogni F, Hevner RF. Bedogni F, et al. Front Mol Neurosci. 2021 Jul 12;14:686034. doi: 10.3389/fnmol.2021.686034. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34321999 Free PMC article.

4

Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors.

Myer DL, Robbins SB, Yin M, Boivin GP, Liu Y, Greis KD, Bahassi el M, Stambrook PJ. Myer DL, et al. Mutat Res. 2011 Sep 1;714(1-2):1-10. doi: 10.1016/j.mrfmmm.2011.02.006. Epub 2011 Mar 3. Mutat Res. 2011. PMID: 21376736 Free PMC article.

5

Regulation of PTEN stability and activity by Plk3.

Xu D, Yao Y, Jiang X, Lu L, Dai W. Xu D, et al. J Biol Chem. 2010 Dec 17;285(51):39935-42. doi: 10.1074/jbc.M110.166462. Epub 2010 Oct 12. J Biol Chem. 2010. PMID: 20940307 Free PMC article.

6

Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions.

Yang Y, Bai J, Shen R, Brown SA, Komissarova E, Huang Y, Jiang N, Alberts GF, Costa M, Lu L, Winkles JA, Dai W. Yang Y, et al. Cancer Res. 2008 Jun 1;68(11):4077-85. doi: 10.1158/0008-5472.CAN-07-6182. Cancer Res. 2008. PMID: 18519666 Free PMC article.

7

Polo-like kinase 3 is required for entry into S phase.

Zimmerman WC, Erikson RL. Zimmerman WC, et al. Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1847-52. doi: 10.1073/pnas.0610856104. Epub 2007 Jan 30. Proc Natl Acad Sci U S A. 2007. PMID: 17264206 Free PMC article.

8

The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity.

Kauselmann G, Weiler M, Wulff P, Jessberger S, Konietzko U, Scafidi J, Staubli U, Bereiter-Hahn J, Strebhardt K, Kuhl D. Kauselmann G, et al. EMBO J. 1999 Oct 15;18(20):5528-39. doi: 10.1093/emboj/18.20.5528. EMBO J. 1999. PMID: 10523297 Free PMC article.

9

Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression.

Chase D, Feng Y, Hanshew B, Winkles JA, Longo DL, Ferris DK. Chase D, et al. Biochem J. 1998 Aug 1;333 ( Pt 3)(Pt 3):655-60. doi: 10.1042/bj3330655. Biochem J. 1998. PMID: 9677325 Free PMC article.

10

Identification by targeted differential display of an immediate early gene encoding a putative serine/threonine kinase.

Donohue PJ, Alberts GF, Guo Y, Winkles JA. Donohue PJ, et al. J Biol Chem. 1995 Apr 28;270(17):10351-7. doi: 10.1074/jbc.270.17.10351. J Biol Chem. 1995. PMID: 7730342 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year